|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
Xenova Group plc
|
|
|
Holding company for drug discovery subsidiaries, developing anti-cancer compounds in clinical stage, and addiction vaccines. Includes candidates for therapeutic focus, investor details, with contacts in Slough and Cambridge, England. (Nasdaq: XNVA)
|
| 2. |
MannKind Corp.
|
|
|
Developing a pulmonary insulin delivery system, and immunotherapy of cancer, by identifying tumor-related antigens, DNA and peptide-based drugs evoking cell-mediated responses. Located in Valencia, California.
|
| 3. |
Avigen, Inc.
|
|
|
Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN)
|
| 4. |
AVI Biopharma, Inc.
|
|
|
Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. Research and manufacturing facilities in Corvallis, Oregon. (Nasdaq: AVII)
|
| 5. |
Novacta Biosystems Ltd.
|
|
|
Drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. Introduces biotransformation technology, lead compounds, key personnel in Hatfield, England.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
